fda compounding semaglutide crackdown october 2025 Compounded Semaglutide: Legal & Safe 2025

National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and

22.39

★★★★☆4.8 (126)

🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these

27.39

★★★★★4.9 (98)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

28.77

★★★★★5.0 (157)

There's lots going on this month at FDA in the world of weight loss drugs. The agency is taking a hard look at the market. Check out these new #FDA Warning Letters

25.42

★★★★★4.7 (84)

How FDA Crackdowns Are Affecting GLP-1 Use In 2025

25.50

★★★★★4.9 (203)

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many

28.91

★★★★★5.0 (176)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

23.92

★★★★★4.8 (132)